Non-tuberculous mycobacteria in cystic fibrosis

J R Soc Med. 2012 Jun;105 Suppl 2(Suppl 2):S14-8. doi: 10.1258/jrsm.2012.12s003.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Comorbidity
  • Cystic Fibrosis / epidemiology*
  • Cystic Fibrosis / microbiology*
  • Cystic Fibrosis / physiopathology
  • Drug Therapy, Combination
  • Ethambutol / therapeutic use
  • Female
  • Humans
  • Macrolides / therapeutic use
  • Male
  • Mycobacterium Infections, Nontuberculous / diagnosis
  • Mycobacterium Infections, Nontuberculous / drug therapy
  • Mycobacterium Infections, Nontuberculous / epidemiology*
  • Nontuberculous Mycobacteria / isolation & purification*
  • Prognosis
  • Respiratory Function Tests
  • Rifampin
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Macrolides
  • Ethambutol
  • Rifampin